Last updated: 7 February 2024 at 6:12pm EST

Fletcher Payne Net Worth




The estimated Net Worth of Fletcher Payne is at least 5.1 千$ dollars as of 19 September 2022. Fletcher Payne owns over 10,000 units of Catalyst Biosciences Inc stock worth over 5,100$ and over the last 9 years Fletcher sold CBIO stock worth over 0$.

Fletcher Payne CBIO stock SEC Form 4 insiders trading

Fletcher has made over 5 trades of the Catalyst Biosciences Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Fletcher bought 10,000 units of CBIO stock worth 6,800$ on 19 September 2022.

The largest trade Fletcher's ever made was buying 10,000 units of Catalyst Biosciences Inc stock on 19 September 2022 worth over 6,800$. On average, Fletcher trades about 1,753 units every 137 days since 2015. As of 19 September 2022 Fletcher still owns at least 10,000 units of Catalyst Biosciences Inc stock.

You can see the complete history of Fletcher Payne stock trades at the bottom of the page.



What's Fletcher Payne's mailing address?

Fletcher's mailing address filed with the SEC is 260 Littlefield Ave, South San Francisco, CA 94080, USA.

Insiders trading at Catalyst Biosciences Inc

Over the last 9 years, insiders at Catalyst Biosciences Inc have traded over 2,614,728$ worth of Catalyst Biosciences Inc stock and bought 81,771 units worth 199,380$ . The most active insiders traders include Jeff HimawanJames E Deerfield Mgmt L.P....Augustine Lawlor. On average, Catalyst Biosciences Inc executives and independent directors trade stock every 62 days with the average trade being worth of 3,315$. The most recent stock trade was executed by Nassim Usman on 9 August 2022, trading 3,250 units of CBIO stock currently worth 1,528$.



What does Catalyst Biosciences Inc do?

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.



What does Catalyst Biosciences Inc's logo look like?

Catalyst Biosciences Inc logo

Complete history of Fletcher Payne stock trades at Aptose Biosciences Inc、Catalyst Biosciences Inc

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
19 Sep 2022 Fletcher Payne
Sr VP、CFO
購入する 10,000 0.68$ 6,800$
19 Sep 2022
10,000
4 Feb 2019 Fletcher Payne
最高財務責任者
オプション行使 1,503 4.63$ 6,959$
4 Feb 2019
3,230
26 Mar 2018 Fletcher Payne
最高財務責任者
オプション行使 59 4.63$ 273$
26 Mar 2018
59
17 Dec 2015 Fletcher Payne
最高財務責任者
購入する 10,000 2.00$ 20,000$
17 Dec 2015
25,032
17 Dec 2015 Fletcher Payne
最高財務責任者
購入する 10,000 2.00$ 20,000$
17 Dec 2015
25,032


Catalyst Biosciences Inc executives and stock owners

Catalyst Biosciences Inc executives and other stock owners filed with the SEC include: